Conversely, blocking Akt phosphorylation with the specific inhibitor MK-2206 2HCI markedly reduced PD-L1 expression and significantly improved the killing rate of CRC cells by PBMCs. The gene discussed is CD274; the disease is colorectal carcinoma.